Covenant Multifamily Offices’s GSK GSK Stock Holding History

Covenant Multifamily Offices’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-6,774	Closed	-$345K	–	145
2020 Q2	$345K	Buy	+6,774	New	+$348K	0.07%	113
2019 Q3	–	Sell	-6,702	Closed	-$335K	–	144
2019 Q2	$335K	Buy	6,702 +4,960	+285%	+$249K	0.07%	118
2019 Q1	$91K	Buy	+1,742	New	+$87K	0.03%	89
2018 Q1	–	Sell	-1,460	Closed	-$65K	–	83
2017 Q4	$65K	Buy	+1,460	New	+$67.4K	0.04%	53

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Covenant Multifamily Offices's GSK Position: Q3 2020 in Review

Covenant Multifamily Offices sold out of GSK (GSK) in Q3 2020, closing a stake of 6,774 shares — an estimated $345K sold.

Covenant Multifamily Offices first reported a position in GSK in Q4 2017 and held it in 4 quarters. The position peaked at $345K in Q2 2020. 826 funds tracked by Wall St. Rank hold GSK as of Q3 2020.

Covenant Multifamily Offices reported no remaining GSK position as of Q3 2020 after selling out during the quarter.
Covenant Multifamily Offices sold 6,774 GSK shares in Q3 2020, an estimated $345K.
Covenant Multifamily Offices first reported a position in GSK in Q4 2017 and held it in 4 quarters.
Covenant Multifamily Offices's GSK position peaked at $345K in Q2 2020.
826 funds tracked by Wall St. Rank held GSK as of Q3 2020.

Based on Covenant Multifamily Offices's 13F filing for Q3 2020, filed 10 Nov 2020.